share_log

Merit Medical Systems (NASDAQ:MMSI) Raised to "Strong-Buy" at StockNews.com

Merit Medical Systems (NASDAQ:MMSI) Raised to "Strong-Buy" at StockNews.com

優點醫療系統公司(納斯達克代碼:MMSI)在StockNews.com被上調至“強力買入”
kopsource ·  2023/01/06 02:41

StockNews.com upgraded shares of Merit Medical Systems (NASDAQ:MMSI – Get Rating) from a buy rating to a strong-buy rating in a report released on Tuesday morning.

在週二上午發佈的一份報告中,斯托克新聞網將默立特醫療系統公司(納斯達克代碼:MMSI-GET Rating)的股票評級從買入上調至強力買入。

Other equities research analysts also recently issued reports about the stock. Raymond James raised their target price on shares of Merit Medical Systems from $71.00 to $72.00 and gave the company an outperform rating in a research note on Thursday, October 27th. Canaccord Genuity Group downgraded shares of Merit Medical Systems from a buy rating to a hold rating and lowered their target price for the company from $73.00 to $72.00 in a research note on Tuesday, December 20th. TheStreet raised shares of Merit Medical Systems from a c+ rating to a b- rating in a report on Friday, September 16th. Piper Sandler raised their price target on shares of Merit Medical Systems from $70.00 to $73.00 in a report on Thursday, October 27th. Finally, Canaccord Genuity Group raised their price target on shares of Merit Medical Systems from $69.00 to $73.00 in a report on Monday, November 7th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Merit Medical Systems presently has a consensus rating of Buy and a consensus price target of $73.50.

其他股票研究分析師最近也發佈了有關該股的報告。雷蒙德·詹姆斯在10月27日週四的一份研究報告中將Merit Medical Systems的目標價從71.00美元上調至72.00美元,並給出了該公司表現優於大盤的評級。在12月20日星期二的一份研究報告中,Canaccel Genuity Group將Merit Medical Systems的股票評級從買入下調至持有評級,並將該公司的目標價從73.00美元下調至72.00美元。華爾街在9月16日星期五的一份報告中將Merit Medical Systems的股票評級從C+上調至B-。派珀·桑德勒在10月27日星期四的一份報告中將他們對Merit醫療系統公司股票的目標價從70.00美元上調至73.00美元。最後,在11月7日星期一的一份報告中,Canaccel Genuity Group將Merit Medical Systems的股票目標價從69.00美元上調至73.00美元。一名投資分析師對該股的評級為持有,四名分析師給予了買入評級,一名分析師對該公司發出了強烈的買入評級。根據MarketBeat的數據,Merit Medical Systems目前的共識評級為買入,共識目標價為73.50美元。

Get
到達
Merit Medical Systems
優點醫療系統
alerts:
警報:

Merit Medical Systems Price Performance

優點醫療系統性價比

NASDAQ MMSI opened at $70.42 on Tuesday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.19 and a current ratio of 2.35. The firm's 50 day moving average price is $70.42 and its 200-day moving average price is $61.85. Merit Medical Systems has a 52-week low of $50.46 and a 52-week high of $76.14. The company has a market cap of $4.01 billion, a PE ratio of 65.20, a P/E/G ratio of 2.24 and a beta of 1.01.

納斯達克MMSI週二開盤報70.42美元。該公司的負債權益比率為0.19,速動比率為1.19,流動比率為2.35。該公司的50日移動均線價格為70.42美元,200日移動均線價格為61.85美元。優點醫療系統公司的股價為50.46美元,為52周低點,52周高點為76.14美元。該公司市值為40.1億美元,市盈率為65.20倍,市盈率為2.24倍,貝塔係數為1.01。

Merit Medical Systems (NASDAQ:MMSI – Get Rating) last announced its earnings results on Wednesday, October 26th. The medical instruments supplier reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.11. The company had revenue of $287.18 million during the quarter, compared to the consensus estimate of $273.03 million. Merit Medical Systems had a net margin of 5.43% and a return on equity of 14.14%. Sell-side analysts forecast that Merit Medical Systems will post 2.57 EPS for the current fiscal year.
優點醫療系統公司(納斯達克代碼:MMSI-GET Rating)最近一次公佈財報是在10月26日星期三。這家醫療器械供應商公佈本季度每股收益為0.64美元,比普遍預期的0.53美元高出0.11美元。該公司本季度營收為2.8718億美元,而市場普遍預期為2.7303億美元。優點醫療系統公司的淨利潤率為5.43%,股本回報率為14.14%。賣方分析師預測,Merit Medical Systems本財年每股收益將達到2.57歐元。

Institutional Inflows and Outflows

機構資金流入和流出

Several institutional investors have recently made changes to their positions in MMSI. BlackRock Inc. raised its holdings in shares of Merit Medical Systems by 6.8% during the third quarter. BlackRock Inc. now owns 9,704,654 shares of the medical instruments supplier's stock worth $548,409,000 after purchasing an additional 617,129 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of Merit Medical Systems by 6.0% during the third quarter. Vanguard Group Inc. now owns 6,700,655 shares of the medical instruments supplier's stock worth $378,653,000 after purchasing an additional 377,858 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in shares of Merit Medical Systems by 61.4% during the third quarter. Bank of New York Mellon Corp now owns 950,734 shares of the medical instruments supplier's stock worth $53,727,000 after purchasing an additional 361,635 shares during the last quarter. Eagle Asset Management Inc. raised its holdings in shares of Merit Medical Systems by 48.4% during the second quarter. Eagle Asset Management Inc. now owns 712,135 shares of the medical instruments supplier's stock worth $38,647,000 after purchasing an additional 232,211 shares during the last quarter. Finally, Fort Washington Investment Advisors Inc. OH purchased a new position in Merit Medical Systems in the third quarter valued at $12,592,000. Hedge funds and other institutional investors own 95.38% of the company's stock.

幾家機構投資者最近改變了他們在MMSI的頭寸。貝萊德股份有限公司在第三季度增持了6.8%的功德醫療系統股份。貝萊德股份有限公司在上個季度增持了617,129股後,現在持有這家醫療器械供應商價值548,409,000美元的股票9,704,654股。先鋒集團(Vanguard Group Inc.)在第三季度增持了Merit Medical Systems的股票6.0%。先鋒集團現在持有這家醫療器械供應商6,700,655股股票,價值378,653,000美元,上個季度又購買了377,858股。紐約梅隆銀行(Bank Of New York Mellon Corp)在第三季度增持了61.4%的Merit Medical Systems股票。紐約梅隆銀行(Bank Of New York Mellon Corp)目前持有這家醫療器械供應商950,734股票,價值53,727,000美元,此前該公司在上一季度額外購買了361,635股票。Eagle Asset Management Inc.在第二季度增持了48.4%的Merit Medical Systems股票。Eagle Asset Management Inc.現在持有這家醫療器械供應商712,135股股票,價值38,647,000美元,此前該公司在上個季度又購買了232,211股票。最後,華盛頓堡投資顧問公司(Fort Washington Investment Advisors Inc.)在第三季度以12,592,000美元收購了Merit Medical Systems的一個新頭寸。對衝基金和其他機構投資者持有該公司95.38%的股票。

About Merit Medical Systems

關於功德醫療系統公司

(Get Rating)

(獲取評級)

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.

優點醫療系統公司設計、開發、製造和營銷用於介入、診斷和治療程序的一次性醫療產品,主要用於心臟病學、放射學、腫瘤學、危重護理和內窺鏡檢查。該公司在心血管和內窺鏡兩個領域開展業務。

Recommended Stories

推薦故事

  • Get a free copy of the StockNews.com research report on Merit Medical Systems (MMSI)
  • Can Chip Gear Maker Lam Continue Its Rally As Earnings Slow?
  • Bed Bath & Beyond Stock Crumbles 24% On Possible Bankruptcy News
  • Why Is Kraft Heinz Moving Higher
  • What will this mean for the Devon Energy stock price this year?
  • Nio Stock, Is This The Bottom ?
  • 免費獲取StockNews.com關於Merit Medical Systems(MMSI)的研究報告
  • 芯片齒輪製造商LAM能否在盈利放緩的情況下繼續上漲?
  • Bed Bath&Beyond股票因可能破產消息暴跌24%
  • 為什麼卡夫亨氏走得更高
  • 這對今年德文能源的股價意味着什麼?
  • 蔚來股,這是底部嗎?

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

接受新聞和評級的優點醫療系統每日-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Merit Medical Systems和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論